Drug Shortage Report for LINEZOLID INJECTION

Last updated on 2022-06-27 History
Report ID 159027
Drug Identification Number 02430827
Brand name LINEZOLID INJECTION
Common or Proper name LINEZOLID INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) LINEZOLID
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 300 mL
ATC code J01XX
ATC description OTHER ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-04-30
Estimated end date 2022-06-24
Actual end date 2022-06-24
Shortage status Resolved
Updated date 2022-06-27
Company comments Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Linezolid Injection 2 mg/mL freeflex® Bag 300 mL effective April 30, 2022 until June 24, 2022. Please note that all available inventory expires April 30, 2022.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-06-27 French Compare
v8 2022-06-27 English Compare
v7 2022-06-08 French Compare
v6 2022-06-08 English Compare
v5 2022-05-30 French Compare
v4 2022-05-30 English Compare
v3 2022-05-01 English Compare
v2 2022-04-20 French Compare
v1 2022-04-20 English Compare

Showing 1 to 9 of 9